July 23, 2013
1 min read
Save

FDA issues 510(k) clearance for Topcon’s Pascal Synthesis laser

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Topcon Medical Laser Systems has received 510(k) clearance from the U.S. Food and Drug Administration for its portable, dual-port, pattern-scanning laser, the Pascal Synthesis, according to a news release.

The device, which is available in 532-nm and 577-nm wavelengths, can be integrated with both Topcon D7 and Haag-Streit-style slit lamps.

The combination will allow physicians the opportunity to use pattern-scanning laser technology to treat retinal disorders such as diabetic retinopathy, age-related macular degeneration and retinal vascular occlusive disease using a slit lamp set up.

Topcon also offers Endpoint Management as an upgrade on the Synthesis lasers, which is intended to provide increased precision, efficiency and control, according to the release.